Product Description: Ruxolitinib is a JAK inhibitor of JAK1, JAK2, and JAK3. JAKs, or Janus-associated kinases, are tyrosine kinases found in the cytoplasm that are known to active the signaling of certain growth factor receptors and cytokines.
CAS Number: 941678-49-5
Molecular Weight: 306.37
Structure: C17H18N6
Compound Purity: >99%